SCHEMBL7302756

SCHEMBL7302756

CCOC(=O)N(CCCCCl)c1ccc([N+](=O)[O-])cc1C(=O)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.43
ALDH1A1 P00352 7/20 0.42
TP53 P04637 2/20 0.41
HTT P42858 1/20 0.41
LMNA P02545 2/20 0.39
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
KMT2A Q03164 4/20 0.39
ADORA3 P0DMS8 1/20 0.39
MAPT P10636 4/20 0.38
HIF1A Q16665 3/20 0.38
MEN1 O00255 3/20 0.38
CYP1A2 P05177 2/20 0.38
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 2/20 0.38
CYP2C19 P33261 2/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
GPR55 Q9Y2T6 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7302767 0.92 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1TP53HTTLMNA
SCHEMBL28560557 0.86 TP53 (0.55) SMN1; SMN2ALDH1A1TP53HTTKDM4E
SCHEMBL7298470 0.83 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1TP53HTTLMNA
SCHEMBL7298114 0.78 SMN1; SMN2 (0.41) SMN1; SMN2ALDH1A1HTTLMNAKDM4E
SCHEMBL7295840 0.78 ALDH1A1 (0.38) SMN1; SMN2ALDH1A1TP53LMNAKDM4E
SCHEMBL28575267 0.77 MAPT (0.39) SMN1; SMN2ALDH1A1TP53HTTLMNA
SCHEMBL7299287 0.77 ALDH1A1 (0.40) SMN1; SMN2ALDH1A1HTTLMNAKDM4E
SCHEMBL7302145 0.76 ALDH1A1 (0.39) SMN1; SMN2ALDH1A1HTTLMNAKDM4E
SCHEMBL6578894 0.76 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1TP53HTTKMT2A
SCHEMBL6579151 0.72 SMN1; SMN2 (0.43) SMN1; SMN2ALDH1A1TP53HTTMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5304560-A Treating CNS disorders; dopamine receptor antagonist FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-04-19 US disclosed
CN-1060841-A Quinazoline derivant and preparation method thereof FUJISAWA PHARMACEUTICAL CO (JP) 1992-05-06 CN disclosed
EP-0481342-A1 Quinazoline derivatives and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-04-22 EP disclosed